Halicin (SU-3327) is a chemical compound that acts as an inhibitor of the enzyme c-Jun N-terminal kinase (JNK).[1][2][3] Originally, it was researched for the treatment of diabetes,[4] but development was not continued for this application due to poor results in testing.